Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 2.67%229.1M | 7.54%361.57M | 26.47%223.14M | 33.94%336.22M | 41.40%176.44M | 25.00%251.03M | 44.77%124.78M | 93.21%200.81M | --86.19M | 383.37%103.93M |
| Operating income | 2.67%229.1M | 7.54%361.57M | 26.47%223.14M | 33.94%336.22M | 41.40%176.44M | 25.00%251.03M | 44.77%124.78M | 93.21%200.81M | 86.19M | 383.37%103.93M |
| Cost of sales | -5.03%-68.18M | -3.83%-110.36M | -8.52%-64.91M | -19.56%-106.28M | -31.94%-59.82M | -8.26%-88.9M | -17.21%-45.34M | -40.23%-82.11M | ---38.68M | -285.22%-58.55M |
| Operating expenses | -5.03%-68.18M | -3.83%-110.36M | -8.52%-64.91M | -19.56%-106.28M | -31.94%-59.82M | -8.26%-88.9M | -17.21%-45.34M | -40.23%-82.11M | -38.68M | -285.22%-58.55M |
| Gross profit | 1.71%160.92M | 9.25%251.21M | 35.67%158.22M | 41.82%229.93M | 46.80%116.62M | 36.59%162.13M | 67.21%79.44M | 161.57%118.7M | 47.51M | 620.09%45.38M |
| Selling expenses | 9.01%-79.31M | 26.09%-164.83M | -0.40%-87.16M | -38.71%-223.01M | -42.20%-86.81M | -38.11%-160.78M | -54.65%-61.05M | -126.68%-116.42M | ---39.48M | -96.73%-51.36M |
| Administrative expenses | -22.48%-38.9M | 17.95%-57.61M | -11.36%-31.76M | 2.46%-70.22M | 15.98%-28.52M | -103.63%-71.99M | -144.45%-33.94M | 21.82%-35.35M | ---13.88M | -316.66%-45.22M |
| Research and development expenses | 38.13%-51.41M | 35.36%-153.41M | 24.11%-83.09M | -6.06%-237.34M | -37.54%-109.49M | -48.07%-223.78M | -62.48%-79.61M | -56.06%-151.13M | ---49M | -0.14%-96.84M |
| Revaluation surplus | 86.89%4.58M | 143.15%21.65M | 107.42%2.45M | -40.94%-50.18M | -3,463.81%-33M | -252.03%-35.61M | --981K | 136.17%23.42M | ---- | -648.56%-64.74M |
| -Changes in the fair value of other assets | 86.89%4.58M | 143.15%21.65M | 107.42%2.45M | -40.94%-50.18M | -3,463.81%-33M | -252.03%-35.61M | --981K | 136.17%23.42M | ---- | -648.56%-64.74M |
| Impairment and provision | ---- | ---- | ---- | ---- | ---- | ---49.1M | ---- | ---- | ---- | ---- |
| -Impairment of intangible assets | ---- | ---- | ---- | ---- | ---- | ---49.1M | ---- | ---- | ---- | ---- |
| Special items of operating profit | -38.32%7.93M | 8.62%40.37M | 122.46%12.86M | 1,357.49%37.17M | 163.27%5.78M | 65.26%2.55M | -473.01%-9.14M | 103.89%1.54M | --2.45M | -1,091.17%-39.72M |
| Operating profit | 113.40%3.82M | 80.04%-62.62M | 78.97%-28.48M | 16.71%-313.65M | -31.08%-135.42M | -136.49%-376.58M | -97.17%-103.31M | 36.93%-159.24M | -52.4M | -91.29%-252.5M |
| Financing cost | -55.32%-3.14M | 3.50%-4M | 9.33%-2.02M | 23.36%-4.15M | 23.53%-2.23M | 72.81%-5.41M | 82.91%-2.92M | 86.40%-19.9M | ---17.06M | -1,068.31%-146.31M |
| Share of profits of associates | -13.69%-26.79M | -24.03%-61.67M | -0.25%-23.56M | -3.17%-49.72M | -53.35%-23.5M | -1,276.07%-48.19M | ---15.33M | ---3.5M | ---- | ---- |
| Share of profit from joint venture company | ---- | ---- | ---- | 30.22%-14.74M | -206,700.00%-14.48M | -211,090.00%-21.12M | 93.75%-7K | -101.40%-10K | ---112K | --716K |
| Special items of earning before tax | --27.07M | 200.86%82.03M | ---- | ---81.33M | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | 101.78%960K | 90.02%-46.26M | 69.22%-54.06M | -2.72%-463.58M | -44.48%-175.63M | -147.08%-451.3M | -74.74%-121.56M | 54.12%-182.65M | -69.57M | -175.45%-398.09M |
| Tax | 14.44%-3.16M | 11.91%-7.01M | 2.20%-3.69M | -156.85%-7.95M | -359.00%-3.77M | -405.06%-3.1M | -64.73%-822K | ---613K | ---499K | ---- |
| After-tax profit from continuing operations | 96.20%-2.2M | 88.70%-53.27M | 67.81%-57.75M | -3.77%-471.53M | -46.59%-179.4M | -147.95%-454.4M | -74.67%-122.38M | 53.96%-183.26M | -70.07M | -175.45%-398.09M |
| Earning after tax | 96.20%-2.2M | 88.70%-53.27M | 67.81%-57.75M | -3.77%-471.53M | -46.59%-179.4M | -147.95%-454.4M | -74.67%-122.38M | 53.96%-183.26M | -70.07M | -175.45%-398.09M |
| Minority profit | 97.37%-34K | ---3.82M | ---1.29M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 96.17%-2.16M | 89.51%-49.45M | 68.53%-56.46M | -3.77%-471.53M | -46.59%-179.4M | -147.95%-454.4M | -74.67%-122.38M | 53.96%-183.26M | -70.07M | -175.45%-398.09M |
| Basic earnings per share | 96.25%-0.0009 | 90.00%-0.02 | 70.00%-0.024 | -5.26%-0.2 | -60.00%-0.08 | -137.50%-0.19 | -66.67%-0.05 | 65.22%-0.08 | -0.03 | -187.50%-0.23 |
| Diluted earnings per share | 96.25%-0.0009 | 90.00%-0.02 | 70.00%-0.024 | -5.26%-0.2 | -60.00%-0.08 | -137.50%-0.19 | -66.67%-0.05 | 65.22%-0.08 | -0.03 | -187.50%-0.23 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | PwC accounting firm | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.